Market Closed -
OTC Markets
13:16:30 2023-11-15 EST
5-day change
1st Jan Change
0.105
USD
-.--%
-.--%
-.--%
Acro Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Acro Biomedical Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was USD 0.2985 million. Net loss was USD 3.93 million. Basic loss per share from continuing operations was USD 0.07.
Acro Biomedical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
23-08-14
CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-08-02
CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
23-07-21
CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
22-11-21
CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
22-08-12
CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
22-05-16
CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
22-04-15
CI
Acro Biomedical Co., Ltd. Auditor Raises 'Going Concern' Doubt
22-04-14
CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
21-11-22
CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021
21-08-23
CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
21-05-24
CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
21-04-02
CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020
20-11-17
CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020
20-08-19
CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020
20-05-19
CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended December 31, 2019
20-03-27
CI
Acro Biomedical Co., Ltd. Determines to Change the Fiscal Year of the Company from the Year Ending September 30 to the Calendar Year
20-01-17
CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the Full Year Ended September 30, 2019
20-01-07
CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the Third Quarter Ended June 30, 2019
19-08-14
CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the Second Quarter Ended March 31, 2019
19-05-15
CI
Acro Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended December 31, 2018
19-02-14
CI
Acro Biomedical Co., Ltd. Announces Earnings Results for the Year Ended September 30, 2018
18-12-28
CI
Acro Biomedical Co., Ltd. Auditor Raises 'Going Concern' Doubt
18-01-15
CI
Arco Biomedical Co., Ltd. will Change its Name to Acro Biomedical Co., Ltd
17-02-27
CI
ACRO Biomedical Co., Ltd Announces Management Changes
17-02-01
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Acro Biomedical Co., Ltd. is principally engaged in the business is the sale of cordyceps related products. The Company is focused on developing and marketing nutritional products that promote wellness and a healthy lifestyle. The Company's business consists of selling cordyceps related products that is used in traditional Chinese medicine. Cordyceps is a fungus, which is a combination of a caterpillar and a fungus, which is found at altitudes above 4500 meters (m) in Sikkim. The Company is involved in the purchase of products from three suppliers in Taiwan and the sale of these products to four unrelated customers. It sells products in bulk to companies who may use the Company's products as ingredients in their products or sell the products they purchase from the Company to their own customers.
More about the company
1st Jan change
Capi.
-.--% 6.3M +19.40% 8.62B +6.26% 7.68B +7.42% 6.38B -6.64% 3.74B -3.06% 1.34B -26.54% 1.12B +20.86% 1.05B -10.58% 913M -18.47% 788M
Special Foods & Wellbeing Products
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
marketscreener.com**derivatives**en**/dynamic-chart/**Premium**Expert**Access**Annual**Monthly**
-40% Limited Time Offer : Our subscriptions help you unlock hidden opportunities.**#000000**/services/solutions/**#fff826**#ff3000**#ffffff**
BENEFIT NOW **0**linear-gradient(180deg, rgba(42,73,76,1) 0%, rgba(28,30,51,1) 53%);**linear-gradient(180deg, rgba(255, 248, 38,1) 0%, rgba(247, 239,1) 53%);**date_fin_hors_prolongation**49**on all our subscriptions**